|
2025-06-18 |
2025-06-17 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
1 000
-1.8%
30,24
27 549 USD
|
1 000
-1.8%
|
30,24
|
100 000 USD
|
|
|
2025-06-12 |
2025-06-11 |
VP
Vente planifiée
|
Flanagan W. Michael
Chief Scientific Officer
Dirigeant
|
20 000
-20.0%
32,88
657 694 USD
|
20 000
-20.0%
|
32,88
|
657 694 USD
|
|
|
2025-06-04 |
2025-06-02 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
5 875
-10.4%
32,48
190 833 USD
|
5 875
-10.4%
|
32,48
|
190 833 USD
|
|
|
2025-05-02 |
2025-05-01 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
5 875
-10.4%
32,40
190 324 USD
|
5 875
-10.4%
|
32,40
|
190 324 USD
|
|
|
2025-04-03 |
2025-04-01 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
329
-0.6%
27,83
9 155 USD
|
329
-0.6%
|
27,83
|
9 155 USD
|
|
|
2025-04-03 |
2025-04-01 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
5 546
-9.9%
27,83
154 331 USD
|
5 546
-9.9%
|
27,83
|
154 331 USD
|
|
|
2025-03-21 |
2025-03-20 |
VP
Vente planifiée
|
Boyce Sarah
President and CEO
Administrateur exécutif
|
31 540
-9.3%
31,06
979 563 USD
|
31 540
-9.3%
|
31,06
|
979 563 USD
|
|
|
2025-03-21 |
2025-03-20 |
VP
Vente planifiée
|
Flanagan W. Michael
Chief Scientific Officer
Dirigeant
|
11 780
-12.8%
31,06
365 868 USD
|
11 780
-12.8%
|
31,06
|
365 868 USD
|
|
|
2025-03-21 |
2025-03-20 |
VP
Vente planifiée
|
Hughes Steven George
Chief Medical Officer
Dirigeant
|
9 578
-11.6%
31,06
297 491 USD
|
9 578
-11.6%
|
31,06
|
297 491 USD
|
|
|
2025-03-21 |
2025-03-20 |
VP
Vente planifiée
|
MacLean Michael F
Chief Financial Officer
Dirigeant
|
7 935
-7.6%
31,06
246 425 USD
|
7 935
-7.6%
|
31,06
|
246 425 USD
|
|
|
2025-03-21 |
2025-03-20 |
VP
Vente planifiée
|
McCarthy Teresa
Chief Human Resources Officer
Dirigeant
|
7 778
-7.4%
31,06
241 583 USD
|
7 778
-7.4%
|
31,06
|
241 583 USD
|
|
|
2025-03-12 |
2025-03-11 |
VP
Vente planifiée
|
Flanagan W. Michael
Chief Scientific Officer
Dirigeant
|
20 000
-17.9%
30,13
602 614 USD
|
20 000
-17.9%
|
30,13
|
602 614 USD
|
|
|
2025-03-04 |
2025-03-03 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
5 875
-10.4%
29,41
172 807 USD
|
5 875
-10.4%
|
29,41
|
172 807 USD
|
|
|
2025-02-05 |
2025-02-03 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
5 875
-10.4%
32,16
188 918 USD
|
5 875
-10.4%
|
32,16
|
188 918 USD
|
|
|
2025-01-23 |
2025-01-22 |
VP
Vente planifiée
|
Gallagher Kathleen P.
Chief Program Officer
Dirigeant
|
5 629
-10.0%
30,16
169 776 USD
|
5 629
-10.0%
|
30,16
|
169 776 USD
|
|
|
2025-01-23 |
2025-01-21 |
VP
Vente planifiée
|
Flanagan W. Michael
Chief Scientific Officer
Dirigeant
|
1 812
-1.9%
28,59
51 809 USD
|
1 812
-1.9%
|
28,59
|
51 809 USD
|
|
|
2025-01-23 |
2025-01-21 |
VP
Vente planifiée
|
Flanagan W. Michael
Chief Scientific Officer
Dirigeant
|
3 860
-4.0%
28,60
110 383 USD
|
3 860
-4.0%
|
28,60
|
110 383 USD
|
|
|
2025-01-23 |
2025-01-21 |
VP
Vente planifiée
|
McCarthy Teresa
Chief Human Resources Officer
Dirigeant
|
1 221
-1.2%
28,60
34 917 USD
|
1 221
-1.2%
|
28,60
|
34 917 USD
|
|
|
2025-01-23 |
2025-01-21 |
VP
Vente planifiée
|
McCarthy Teresa
Chief Human Resources Officer
Dirigeant
|
1 738
-1.6%
28,59
49 695 USD
|
1 738
-1.6%
|
28,59
|
49 695 USD
|
|
|
2025-01-23 |
2025-01-21 |
VP
Vente planifiée
|
Boyce Sarah
President and CEO
Administrateur exécutif
|
5 659
-1.6%
28,59
161 817 USD
|
5 659
-1.6%
|
28,59
|
161 817 USD
|
|
